A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma
Clinical trial NCT07732023 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07732023
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2028-07-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.